Stroke risk assessment in atrial fibrillation

Stavros Apostolakis; Gregory Y H Lip

doi:10.2217/EBO.12.47

Stroke risk assessment in atrial fibrillation

Stavros Apostolakis^*, Gregory Y H Lip

^*Corresponding author for this work

College of Health and Life Sciences

Research output: Chapter in Book/Published conference output › Chapter

Abstract

Atrial fibrillation is associated with increased risk for thromboembolism. The risk of atrial fibrillation-related thromboembolism is not homogenous and it is influenced by the presence of comorbid stroke risk factors. Estimating risk of thromboembolism is an important first step in the management of patients with atrial fibrillation. CHA2DS2-VASc score is a useful clinical tool that can aid decision making in antithrombotic management of patients with atrial fibrillation. Only truly low-risk patients with atrial fibrillation (CHA2DS2-VASc score = 0) will not benefit from oral anticoagulation.

Original language	English
Title of host publication	Stroke Prevention in Atrial Fibrillation
Publisher	Future Medicine
Pages	11-28
Number of pages	18
ISBN (Print)	978-1-78084-036-9, 978-1-78084-118-2
DOIs	https://doi.org/10.2217/EBO.12.47
Publication status	Published - 1 Oct 2012

Access to Document

10.2217/EBO.12.47

Cite this

@inbook{a8daf79916b8424ab4476b85223ab06d,

title = "Stroke risk assessment in atrial fibrillation",

abstract = "Atrial fibrillation is associated with increased risk for thromboembolism. The risk of atrial fibrillation-related thromboembolism is not homogenous and it is influenced by the presence of comorbid stroke risk factors. Estimating risk of thromboembolism is an important first step in the management of patients with atrial fibrillation. CHA2DS2-VASc score is a useful clinical tool that can aid decision making in antithrombotic management of patients with atrial fibrillation. Only truly low-risk patients with atrial fibrillation (CHA2DS2-VASc score = 0) will not benefit from oral anticoagulation.",

author = "Stavros Apostolakis and Lip, {Gregory Y H}",

year = "2012",

month = oct,

day = "1",

doi = "10.2217/EBO.12.47",

language = "English",

isbn = "978-1-78084-036-9",

pages = "11--28",

booktitle = "Stroke Prevention in Atrial Fibrillation",

publisher = "Future Medicine",

address = "United Kingdom",

}

TY - CHAP

T1 - Stroke risk assessment in atrial fibrillation

AU - Apostolakis, Stavros

AU - Lip, Gregory Y H

PY - 2012/10/1

Y1 - 2012/10/1

N2 - Atrial fibrillation is associated with increased risk for thromboembolism. The risk of atrial fibrillation-related thromboembolism is not homogenous and it is influenced by the presence of comorbid stroke risk factors. Estimating risk of thromboembolism is an important first step in the management of patients with atrial fibrillation. CHA2DS2-VASc score is a useful clinical tool that can aid decision making in antithrombotic management of patients with atrial fibrillation. Only truly low-risk patients with atrial fibrillation (CHA2DS2-VASc score = 0) will not benefit from oral anticoagulation.

AB - Atrial fibrillation is associated with increased risk for thromboembolism. The risk of atrial fibrillation-related thromboembolism is not homogenous and it is influenced by the presence of comorbid stroke risk factors. Estimating risk of thromboembolism is an important first step in the management of patients with atrial fibrillation. CHA2DS2-VASc score is a useful clinical tool that can aid decision making in antithrombotic management of patients with atrial fibrillation. Only truly low-risk patients with atrial fibrillation (CHA2DS2-VASc score = 0) will not benefit from oral anticoagulation.

UR - http://www.scopus.com/inward/record.url?scp=84956793903&partnerID=8YFLogxK

U2 - 10.2217/EBO.12.47

DO - 10.2217/EBO.12.47

M3 - Chapter

AN - SCOPUS:84956793903

SN - 978-1-78084-036-9

SN - 978-1-78084-118-2

SP - 11

EP - 28

BT - Stroke Prevention in Atrial Fibrillation

PB - Future Medicine

ER -

Stroke risk assessment in atrial fibrillation

Abstract

Access to Document

Other files and links

Fingerprint

Cite this